Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of Literature

Chemotherapy agents for patients with metastatic castration-resistant prostate cancer (mCRPC) include docetaxel and cabazitaxel. Although docetaxel is approved in the first-line treatment setting, a few studies have shown that selected patients can benefit from docetaxel rechallenge. We, here, repor...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Di Lorenzo, Giuseppe, Pagliuca, Martina, Perillo, Teresa, Benincasa, Alfonso, Bosso, Davide, De Placido, Sabino, Buonerba, Carlo
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2016
Fag:
5700
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4998742/
https://ncbi.nlm.nih.gov/pubmed/27057826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002754
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker